Nearly 30 million adults in the United States experience alcohol use disorder (AUD), but the vast majority of people with this condition do not receive treatment. A new study led by Boston University School of […]
New research being presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that […]
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led by University of Arizona Cancer Center researchers and published in the […]
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies.This article was originally published on MedicalXpress.com
Pain and symptom management are important parts of caring for adults living with cerebral palsy.This article was originally published on MedicalXpress.com
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins Medicine investigators report, based […]
Cardiovascular diseases are the world’s leading cause of death, and high blood pressure, or hypertension, affects more than 1 billion people globally, with most living in low- and middle-income countries.This article was originally published on […]
It was a scene that doctors saw play out over and over during the COVID-19 pandemic, said David Pate, the former president and CEO of St. Luke’s Health System.This article was originally published on MedicalXpress.com
The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor antibody-positive and […]
The European Commission said Wednesday that it had given formal approval for Leqembi, a long-awaited new treatment for early-stage Alzheimer’s disease, to be sold in the EU under strict conditions.This article was originally published on […]
© 2025 SimplyWell.ca